Interleukin-17A (IL-17A) secreted by chemotherapy-treated human CAFs promoted the colorectal cancer initiating cell (CIC) self-renewal and tumor growth displaying the conventional chemotherapy resistance features (Lotti et al. 2013). The gene discussed is IL17A; the disease is neoplasm.